Literature DB >> 11498901

An analysis of therapeutic effect of drug acupoint application in 209 cases of allergic asthma.

X Lai1, Y Li, Z Fan, J Zhang, B Liu.   

Abstract

Both therapies of traditional crude herb moxibustion and drug acupoint application were used in 209 cases of allergic asthma to compare their long-term and short-term therapeutic effects and to analyze the relationship between clinic therapeutic effects of both therapies and differential types of the disease. The results showed that the short-term total effective rate in the group of drug acupoint application was higher than that in the group of traditional crude herb moxibustion, the therapeutic effects of drug acupoint application being closely related to differential types. Analysis also shows the best short-term therapeutic effect was in the type of heat in the lung while the poorest effect in the type of deficiency of the kidney-yang.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498901

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

1.  Association between skin reactions and efficacy of summer acupoint application treatment on chronic pulmonary disease: A prospective study.

Authors:  Xia-qiu Wu; Jin Peng; Guo-qin Li; Hui-ping Su; Guang-xia Liu; Bao-yan Liu
Journal:  Chin J Integr Med       Date:  2016-04-09       Impact factor: 1.978

2.  Acupoint herbal plaster for patients with primary dysmenorrhea: study protocol for a randomized controlled trial.

Authors:  Siyi Yu; Yueqiang Wen; Wanting Xia; Mingxiao Yang; Zhengtao Lv; Xiaoji Li; Wenyao Li; Sha Yang; Youping Hu; Fanrong Liang; Jie Yang
Journal:  Trials       Date:  2018-07-03       Impact factor: 2.279

3.  The effectiveness of moxibustion: an overview during 10 years.

Authors:  Song-Yi Kim; Younbyoung Chae; Seung Min Lee; Hyejung Lee; Hi-Joon Park
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

4.  Efficacy of Sanfujiu to treat allergies: patient outcomes at 1 year after treatment.

Authors:  Chen-Jei Tai; Chia-Pei Chang; Chung-Yu Huang; Li-Yin Chien
Journal:  Evid Based Complement Alternat Med       Date:  2006-11-24       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.